Gene · 9965
Papers4,178
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,178
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum protein profiles in lupus nephritis associated with initial-onset systemic lupus erythematosus: Characterization through PEA immunoassay and preliminary development of predictive model. | Cytokine | 2026 | 41192154 | PubTator, text mining | PubMed |
| Development of a series of novel potent and selective irreversible covalent FGFR4 inhibitors with a mix-and-match strategy. | Eur J Med Chem | 2026 | 41187564 | PubTator, text mining | PubMed |
| Clinical and Proteomic Profiling of Inflammatory Mediators in Henoch-Schönlein Purpura: Oncostatin M as a Key Cytokine Associated with Disease Severity. | Int Arch Allergy Immunol | 2026 | 40875710 | PubTator, text mining | PubMed |
| Fibroblast growth factor 19 in combination with liver fibrosis markers for non-invasive diagnosis of primary biliary cholangitis-associated cirrhosis. | Clin Chim Acta | 2026 | 40854399 | PubTator, text mining | PubMed |
| Causal Association of 91 Circulating Inflammatory Proteins with Allergic Rhinitis: A Mendelian Randomization Study. | Int Arch Allergy Immunol | 2026 | 40759088 | PubTator, text mining | PubMed |
| Circulating Inflammatory Proteins and Age-related Macular Degeneration: New Insights from Mendelian Randomization. | Comb Chem High Throughput Screen | 2026 | 40326035 | PubTator, text mining | PubMed |
| Nuclear Receptor-Targeted Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease. | Int J Drug Discov Pharm | 2025 | 41938103 | PubTator, text mining | PubMed |
| Pathology and Therapeutic Significance of Fibroblast Growth Factors. | Targets (Basel) | 2025 | 41743400 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
Interventional effects of mesenchymal stem cells on epithelial-mesenchymal transition in head and neck squamous cell carcinoma and underlying mechanisms: a systematic review and meta-analysis of in vitro studies. | Front Immunol | 2025 | 41635849 | PubTator, text mining | PubMed |
| Molecular Characterization and Functional Insights into Goose IGF2BP2 During Skeletal Muscle Development. | Animals (Basel) | 2025 | 41514747 | PubTator, text mining | PubMed |
| Impact of Bariatric Surgery Type on Adipokines, Myokines, and Hepatokines: An 18-Month Prospective, Observational, Open-Label Study. | Physiol Res | 2025 | 41511104 | PubTator, text mining | PubMed |
| Secondary bile acids and host metabolism: crosstalk, signaling pathways and therapeutic frontiers. | Eur Rev Med Pharmacol Sci | 2025 | 41489239 | PubTator, text mining | PubMed |
Fibroblast Growth Factor 19 (FGF-19) Expression in Glycoresistant Human Umbilical Cord Mesenchymal Stem Cells (ghUC-MSCs) and Its Regulatory Effect on Glucose Metabolism in Insulin-Resistant Hepatocytes. | Dose Response | 2025 | 41466850 | PubTator, text mining | PubMed |
| Role of FXR Agonist in Cholestasis Following Live Donor Liver Transplantation: A Randomized Open-Label Trial. | Cureus | 2025 | 41458807 | PubTator, text mining | PubMed |
| Combined concentrations and genetic variability of fibroblast growth factors predict cardiovascular risk in renal patients. | iScience | 2025 | 41446738 | PubTator, text mining | PubMed |
| Microbiome-derived bile acids as endogenous regenerative mediators in liver repair. | Regen Ther | 2025 | 41424618 | PubTator, text mining | PubMed |
| Association between inflammatory cytokines and prostate cancer: a bidirectional Mendelian randomization study. | Arch Med Sci | 2025 | 41403614 | PubTator, text mining | PubMed |
| Relationship Between the Levels of 91 Circulating Inflammatory Proteins and Ovarian-Related Diseases: A Bidirectional Mendelian Randomization Study. | Int J Womens Health | 2025 | 41395121 | PubTator, text mining | PubMed |
| Signaling of Mitogenic and Metabolic Activities by Fibroblast Growth Factors. | J Cell Signal | 2025 | 41394119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9965/papers?page=7